NASDAQ:PULM Pulmatrix Q3 2026 Earnings Results & Report $1.42 +0.08 (+5.97%) Closing price 04:00 PM EasternExtended Trading$1.37 -0.05 (-3.80%) As of 04:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Pulmatrix beat analyst earnings expectations in its Q3 2026 results, released November 17, 2026. The company reported EPS of -$0.34 versus the -$2.00 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 17, 2026TimeBefore Market OpensConference Call DateNovember 16, 2026Conference Call7:00 AM ET Pulmatrix EPS ResultsActual EPS-$0.34Consensus EPS -$2.00Beat/MissBeat by +$1.66One Year Ago EPSN/APulmatrix Revenue ResultsActual RevenueN/AExpected Revenue$1.53 millionBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Pulmatrix Q3 2026 Earnings FAQ Did Pulmatrix beat earnings estimates for Q3 2026? Pulmatrix (NASDAQ:PULM) reported earnings of -$0.34 per share for Q3 2026, beating the consensus estimate of -$2.00. The report was announced on Tuesday, November 17, 2026. Pulmatrix Earnings HeadlinesPulmatrix Q3 Loss Widens; Expects Eos SENOLYTIX Merger To Close In November; Stock UpNovember 18 at 9:59 AM | rttnews.comPulmatrix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 17 at 1:30 PM | marketscreener.comMThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 19 at 1:00 AM | Digest Publishing (Ad)Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on MergerNovember 17 at 8:05 AM | prnewswire.comEos SENOLYTIX's PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International ConferenceNovember 9, 2026 | globenewswire.comEos SENOLYTIX Reports Preserved Motor Function In Aged Rats With PTC-2105; Stock DownOctober 30, 2026 | rttnews.comSee More Pulmatrix Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Pulmatrix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pulmatrix and other key companies, straight to your email. Email Address About PulmatrixPulmatrix (NASDAQ:PULM) is a clinical-stage biopharmaceutical company developing inhaled therapies. Its proprietary iSPERSE technology is designed to deliver dry-powder medicines to the lungs, and the company’s work has included treatments for respiratory diseases as well as medicines delivered through the lungs for other conditions. Among its drug candidates, PUR1900 is an inhaled formulation of itraconazole being developed for allergic bronchopulmonary aspergillosis, a lung condition associated with fungal sensitivity. PUR3100 is an inhaled formulation of dihydroergotamine being studied as a potential treatment for acute migraine. Founded in 2003, Pulmatrix is based in the United States. Its candidates are in clinical development, and the company’s activities focus on research and development rather than marketing approved medicines.View Pulmatrix ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.